Immunocore Holdings plc SEC filings IMCR

Immunocore Holdings plc has 279 filings in SEC EDGAR's recent list, going back to Apr 13, 2016. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Immunocore Holdings plc SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 28, 2026 May 27, 2026
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 21, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale Apr 8, 2026 —
144 Notice of proposed sale Mar 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2026 —
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 3, 2025 —
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 12, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 5, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
4 Insider transaction Mar 19, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 17, 2025 —
144 Notice of proposed sale Mar 14, 2025 —
4 Insider transaction Feb 27, 2025 Feb 25, 2025
3 Initial insider ownership Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 19, 2025 Feb 17, 2025
4 Insider transaction Feb 19, 2025 Feb 17, 2025
4 Insider transaction Feb 19, 2025 Feb 17, 2025
4 Insider transaction Feb 19, 2025 Feb 17, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Jan 3, 2025 Jan 1, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Sep 10, 2024 —
4 Insider transaction May 29, 2024 May 28, 2024
3 Initial insider ownership May 29, 2024 May 28, 2024
3 Initial insider ownership May 29, 2024 May 28, 2024
4 Insider transaction May 28, 2024 May 23, 2024
4 Insider transaction May 28, 2024 May 23, 2024
4 Insider transaction May 28, 2024 May 23, 2024
4 Insider transaction May 28, 2024 May 23, 2024
4 Insider transaction May 28, 2024 May 23, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
SC 13G Ownership over 5% (passive) Mar 11, 2024 —
SC 13D/A Amended ownership over 5% (active) Mar 7, 2024 —
4 Insider transaction Mar 1, 2024 Feb 28, 2024
4 Insider transaction Feb 28, 2024 Feb 26, 2024
144 Notice of proposed sale Feb 26, 2024 —
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 1, 2024 —
4 Insider transaction Jan 5, 2024 Jan 3, 2024
144 Notice of proposed sale Jan 3, 2024 —
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
3 Initial insider ownership Jan 2, 2024 Jan 2, 2024
144 Notice of proposed sale Dec 27, 2023 —
144 Notice of proposed sale Dec 20, 2023 —
144 Notice of proposed sale Nov 30, 2023 —
144 Notice of proposed sale Nov 16, 2023 —
144 Notice of proposed sale Nov 6, 2023 —
144 Notice of proposed sale Oct 2, 2023 —
SC 13D/A Amended ownership over 5% (active) Sep 18, 2023 —
144 Notice of proposed sale Aug 25, 2023 —
144 Notice of proposed sale Aug 17, 2023 —
144 Notice of proposed sale Jul 12, 2023 —
SC 13D/A Amended ownership over 5% (active) Jun 15, 2023 —
144 Notice of proposed sale Jun 5, 2023 —
144 Notice of proposed sale May 8, 2023 —
144 Notice of proposed sale Apr 19, 2023 —
144 Notice of proposed sale Apr 17, 2023 —
144 Notice of proposed sale Apr 17, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
SC 13D/A Amended ownership over 5% (active) Jan 17, 2023 —
SC 13D/A Amended ownership over 5% (active) Jan 4, 2023 —
SC 13D/A Amended ownership over 5% (active) Dec 20, 2022 —
SC 13G/A Amended ownership over 5% (passive) Sep 7, 2022 —
SC 13D Ownership over 5% (active) Jul 21, 2022 —
SC 13D/A Amended ownership over 5% (active) Jul 20, 2022 —
SC 13G Ownership over 5% (passive) Mar 17, 2022 —
SC 13G Ownership over 5% (passive) Feb 18, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2022 —
SC 13G Ownership over 5% (passive) Feb 10, 2022 —
SC 13G Ownership over 5% (passive) Oct 15, 2021 —
SC 13D Ownership over 5% (active) May 20, 2021 —
SC 13G Ownership over 5% (passive) Apr 19, 2021 —
SC 13G Ownership over 5% (passive) Feb 16, 2021 —
SC 13G Ownership over 5% (passive) Apr 13, 2016 —

Showing 141 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IMCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Oxfordshire, United Kingdom
SEC filer status
Large accelerated filer
SEC CIK
1671927
Former names
Immunocore Ltd (until Feb 1, 2021)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.